Live Breaking News & Updates on Idney insufficiency
Stay updated with breaking news from Idney insufficiency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new analysis of a large contemporary registry of patients with cardiogenic shock has shown worse outcomes for women than men, driven particularly by those with shock related to heart failure.
Now-discontinued "Dr. Ergin's SugarMD Advanced Glucose Support" was found to contain glyburide and metformin, which are only available by prescription.
The findings provide support for potentially using aprocitentan in patients with BP that remains elevated despite treatment with three established antihypertensive drug classes and with stage 3 CKD.
Comparing safety profiles of piperacillin-tazobactam and cefepime could help in choosing the safer empirical therapy for emergency department patients with suspected sepsis, suggests a new JAMA study.
The US Food and Drug Administration has approved Ardelyx's drug to treat high phosphate levels in patients with chronic kidney disease, the company said, more than 2 years after it was initially rejected.
Dapagliflozin became the first SGLT2 inhibitor approved for CKD alone just over 2 years ago, but uptake has lagged. Could a similar label gain for empagliflozin, plus a new recommendation, spark change?
Chronic kidney disease is associated with a more than sevenfold increase in the risk for sudden cardiac arrest among US residents of Hispanic or Latinx ethnicity, new data suggest.
Three times a week, Rachel Napaltjarri, an Aboriginal woman suffering from end-stage kidney failure, receives lifesaving dialysis in a mobile medical unit.